How Big Is the Drug Delivery Device Market?
According to 6Wresearch internal database and industry insights, the
Global Drug Delivery Device Market was valued at USD 28.5 Billion in 2024 and is expected to reach USD 52.4 Billion by 2031, growing at a compound annual growth rate of 5.75% during the forecast period (2025-2031).
This expansion is driven by growing chronic disease prevalence, increased innovation in self-administration technologies, and the global shift towards minimally invasive delivery methods for better patient outcomes.
Growth Factors of the Drug Delivery Device Market
- Increasing geriatric population and associated chronic illnesses such as diabetes and cardiovascular disorders
- Demand for controlled and targeted drug release technologies
- Extensive adoption of biologics and personalized medicine requiring advanced delivery systems
- Rising healthcare access in developing regions promoting self-administered devices
- Rapid innovations in microneedle patches, smart inhalers, and implantable pumps
- Robust R&D funding from pharmaceutical companies and government institutions
Drug Delivery Device Market Trends
Drug Delivery Device Market is evolving rapidly, with key trends including the growth of wearable and connected devices for real-time monitoring and drug administration, increased adoption of needle-free injectors for improved compliance, and the integration of AI in dosage customization. Additionally, rising regulatory approvals and strategic collaborations between medtech firms and pharmaceutical companies are accelerating device availability globally.
Emerging Developments in Drug Delivery Device Market
In general, recent innovations in the Drug Delivery Device Industry include bio-responsive drug delivery systems that release medications based on body triggers like pH or glucose levels, and 3D-printed drug delivery implants that can be customized for individual patients. Drug Delivery Device Market is also witnessing a push towards sustainable device designs using biodegradable materials and digital platforms that track patient usage and ensure adherence.
Major Companies in the Drug Delivery Device Industry
- Medtronic plc
- Ypsomed AG
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- Insulet Corporation
- Nemera
How Big Is the Drug Delivery Device Market : FAQ's
The market is was valued at USD 28.5 Billion in 2024 and is expected to reach USD 52.4 Billion by 2031, growing at a CAGR of 10.4%.
Key drivers include increasing prevalence of chronic conditions, growing self-care demand, and innovations in minimally invasive delivery methods.
Integration of digital health tools, AI, and IoT is enabling remote monitoring, personalized dosing, and better patient adherence.
North America leads due to advanced healthcare infrastructure.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com